A fresh study reveals a modest benefit tied to the implementation of antimalarial therapy in tackling the COVID-19 pandemic. The latest findings highlight a 15% decrease in symptomatic corona cases amongst individuals utilizing hydroxychloroquine as compared to a placebo. In parallel, the study also elucidated a considerable decline in all types of respiratory ailments, along…